- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01338402
Evaluation of the Performance of AIR OPTIX® COLORS
February 19, 2014 updated by: CIBA VISION
The purpose of this study was to assess the ocular response to and performance of the cosmetically printed silicone hydrogel contact lens AIR OPTIX® COLORS compared to FRESHLOOK® COLORBLENDS.
Study Overview
Status
Completed
Conditions
Detailed Description
The study was conducted in two phases.
Phase 1 was an adaptation phase where participants wore AIR OPTIX® AQUA contact lenses bilaterally (same product in both eyes) on a daily wear basis for 1 week.
In Phase 2, participants wore AIR OPTIX® COLORS and FRESHLOOK® COLORBLENDS contact lenses contralaterally (different product in each eye) on a daily wear basis for 4 weeks.
Study Type
Interventional
Enrollment (Actual)
47
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Waterloo, Ontario, Canada, N2L 3G1
- Centre for Contact Lens Research, University of Waterloo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
17 years and older (ADULT, OLDER_ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Full legal capacity to volunteer;
- Read and sign information and consent letter;
- Willing and able to follow instructions and maintain the appointment schedule;
- Ocular examination in the last two years;
- Currently wears soft contact lenses on a daily wear basis;
- Contact lens prescription between -1.50 diopters and -5.00 diopters;
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
- Any ocular disease;
- Any systemic condition that may affect a study outcome variable;
- Any systemic or topical medications that may affect ocular health;
- Known sensitivity to the diagnostic pharmaceuticals used in the study;
- Unable to achieve an acceptable fit with the study lenses;
- Anisometropia >1.00 diopter or astigmatism >0.75 diopter;
- Use of lubricating/rewetting eye drops.
- Other protocol-defined exclusion criteria may apply.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: AIR OPTIX® AQUA
Lotrafilcon B contact lenses worn in both eyes on a daily wear basis for one week in Phase 1.
|
Silicone hydrogel contact lens
Other Names:
|
EXPERIMENTAL: AIR OPTIX® COLORS
Lotrafilcon B contact lens with color randomly assigned to one eye, with phemfilcon A contact lens with color in the fellow eye for contralateral wear.
Both products worn on a daily wear basis for 4 weeks in Phase 2. A replacement phemfilcon A lens was dispensed at the Week 2 visit.
|
Silicone hydrogel contact lens with color
Other Names:
|
ACTIVE_COMPARATOR: FRESHLOOK® COLORBLENDS
Phemfilcon A contact lens with color randomly assigned to one eye, with lotrafilcon B contact lens with color in the fellow eye for contralateral wear.
Both products worn on a daily wear basis for 4 weeks in Phase 2. A replacement phemfilcon A lens was dispensed at the Week 2 visit.
|
Hydrogel contact lens with color
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Visual Acuity
Time Frame: Phase 2: Up to Week 4
|
Phase 2: Up to Week 4
|
Corneal Staining
Time Frame: Phase 2: Up to Week 4
|
Phase 2: Up to Week 4
|
Conjunctival Staining
Time Frame: Phase 2: Up to Week 4
|
Phase 2: Up to Week 4
|
Surface Regularity Index (SRI)
Time Frame: Up to Phase 2, Week 4
|
Up to Phase 2, Week 4
|
Surface Asymmetry Index (SAI)
Time Frame: Up to Phase 2, Week 4
|
Up to Phase 2, Week 4
|
Subjective ratings
Time Frame: Phase 2: Up to Week 4
|
Phase 2: Up to Week 4
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Desmond Fonn, MOptom, FAAO, University of Waterloo Centre for Contact Lens Research
- Principal Investigator: Lyndon Jones, PhD, FCOptom, FAAO, University of Waterloo Centre for Contact Lens Research
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2011
Primary Completion (ACTUAL)
March 1, 2012
Study Completion (ACTUAL)
March 1, 2012
Study Registration Dates
First Submitted
April 15, 2011
First Submitted That Met QC Criteria
April 18, 2011
First Posted (ESTIMATE)
April 19, 2011
Study Record Updates
Last Update Posted (ESTIMATE)
February 20, 2014
Last Update Submitted That Met QC Criteria
February 19, 2014
Last Verified
February 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P-368-C-108
- P/363/10/C (OTHER: University of Waterloo)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
He Eye HospitalNot yet recruiting
-
University of BradfordCoopervision, Inc.; University of HuddersfieldNot yet recruiting
-
Visioneering Technologies, IncRecruitingMyopiaUnited States, Canada, Hong Kong, Singapore
-
University Eye Hospital, FreiburgRecruiting
-
Shanghai 10th People's HospitalCompletedMyopia | Myopia, ProgressiveChina
-
Tianjin Eye HospitalActive, not recruiting
-
Tianjin Eye HospitalCompleted
-
Sultan Qaboos UniversityChristian Medical College, Vellore, IndiaUnknown
-
Peking University People's HospitalUnknownProgressive MyopiaChina
-
Shanghai Eye Disease Prevention and Treatment CenterNot yet recruiting
Clinical Trials on Lotrafilcon B contact lens with color
-
CIBA VISIONCompleted
-
Alcon ResearchCompleted
-
Alcon ResearchCompletedRefractive Error | Myopia
-
CIBA VISIONCompletedCosmetic Appearance
-
Johnson & Johnson Vision Care, Inc.Visioncare Research Ltd.Completed
-
CIBA VISIONUniversity of WaterlooCompleted
-
CIBA VISIONCompleted